Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,144 | 58,042 | 65,111 | 54,677 | 97,473 |
| Marketable Securities | 202,962 | 155,027 | 246,595 | 251,018 | 326,681 |
| Receivables | 69,021 | 57,315 | 56,573 | 52,060 | 51,132 |
| Other current assets | 23,022 | 56,155 | 30,825 | 28,754 | 32,559 |
| TOTAL | $353,571 | $326,539 | $399,104 | $386,509 | $507,845 |
| Non-Current Assets | |||||
| PPE Net | 105,549 | 106,810 | 93,368 | 86,723 | 83,464 |
| Investments And Advances | 570,351 | 602,232 | 526,163 | 540,495 | 423,571 |
| Intangibles | 92,443 | 159,170 | 161,028 | 163,044 | 165,108 |
| Other Non-Current Assets | 98,050 | 39,012 | 52,576 | 53,114 | 55,340 |
| TOTAL | $866,393 | $907,224 | $833,135 | $843,376 | $727,483 |
| Total Assets | $1,219,964 | $1,233,763 | $1,232,239 | $1,229,885 | $1,235,328 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,364 | 19,805 | 19,873 | 19,616 | 15,360 |
| Accrued Expenses | 24,279 | 23,862 | 26,425 | 25,918 | 30,737 |
| Other current liabilities | 29,844 | 29,911 | 29,041 | 30,002 | 25,738 |
| TOTAL | $72,899 | $73,990 | $75,751 | $75,949 | $73,018 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,838 | 18,187 | 21,072 | 20,269 | 27,247 |
| TOTAL | $17,906 | $24,875 | $27,640 | $27,290 | $29,024 |
| Total Liabilities | $90,805 | $98,865 | $103,391 | $103,239 | $102,042 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,829 | 30,587 | 30,297 | 29,924 | 29,785 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 590,467 | 596,355 | 611,003 | 619,713 | 633,175 |
| Other shareholders' equity | -4,437 | 5,631 | -4,578 | -4,399 | -1,610 |
| TOTAL | $1,129,159 | $1,134,898 | $1,128,848 | $1,126,646 | $1,133,286 |
| Total Liabilities And Equity | $1,219,964 | $1,233,763 | $1,232,239 | $1,229,885 | $1,235,328 |